Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans

Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans

Item
http://www.wikidata.org/entity/Q28174827
Q28163123
sameAs
The Journal of Inflammation.NSAIDs: gastroprotection or selective COX-2 inhibitor?A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirinCOX-2 inhibitors compared and contrasted.Gastrointestinal side effects of NSAIDs - pharmacoeconomic implications.Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis.Valdecoxib for treatment of primary dysmenorrhea. A randomized, double-blind comparison with placebo and naproxen.Review article: The pharmacological properties and clinical use of valdecoxib, a new cyclo-oxygenase-2-selective inhibitor.Rofecoxib: an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects.Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trialIncidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind studyRofecoxib in the acute treatment of migraine: a randomized controlled clinical trial.Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.Characterization of etoricoxib, a novel, selective COX-2 inhibitor.The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study.Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis.
P2860

Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans

Item
http://www.wikidata.org/entity/Q28174827
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@ast
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@en
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@nl
type
label
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@ast
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@en
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@nl
prefLabel
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@ast
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@en
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Review article: the gastrointe ...... of cyclooxygenase-2, in humans
@en
P2093
P2860
P304
P31
P356
10.1046/J.1365-2036.2001.00894.X
P407
P433
P478
P577
P5875
P698